These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35574378)

  • 1. Prediction of Pathogenic Factors in Dysbiotic Gut Microbiomes of Colorectal Cancer Patients Using Reverse Microbiomics.
    Wang H; Zhang K; Wu L; Qin Q; He Y
    Front Oncol; 2022; 12():882874. PubMed ID: 35574378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse Microbiomics: A New Reverse Dysbiosis Analysis Strategy and Its Usage in Prediction of Autoantigens and Virulent Factors in Dysbiotic Gut Microbiomes From Rheumatoid Arthritis Patients.
    Wang H; Ong E; Kao JY; Sun D; He Y
    Front Microbiol; 2021; 12():633732. PubMed ID: 33717026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.
    Shariati A; Razavi S; Ghaznavi-Rad E; Jahanbin B; Akbari A; Norzaee S; Darban-Sarokhalil D
    Infect Agent Cancer; 2021 Jun; 16(1):41. PubMed ID: 34108031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
    Kumar A; Thotakura PL; Tiwary BK; Krishna R
    BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.
    Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J
    Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated
    Alturki NA; Mashraqi MM; Jalal K; Khan K; Basharat Z; Alzamami A
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
    Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Long Non-Coding RNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer.
    Fan S; Xing J; Jiang Z; Zhang Z; Zhang H; Wang D; Tang D
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer.
    Gao R; Zhu Y; Kong C; Xia K; Li H; Zhu Y; Zhang X; Liu Y; Zhong H; Yang R; Chen C; Qin N; Qin H
    Front Cell Infect Microbiol; 2021; 11():657867. PubMed ID: 34307189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of changes in microbiome compositions related to the prognosis of colorectal cancer patients based on tissue-derived 16S rRNA sequences.
    Choi S; Chung J; Cho ML; Park D; Choi SS
    J Transl Med; 2021 Nov; 19(1):485. PubMed ID: 34844611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer.
    Okuda S; Shimada Y; Tajima Y; Yuza K; Hirose Y; Ichikawa H; Nagahashi M; Sakata J; Ling Y; Miura N; Sugai M; Watanabe Y; Takeuchi S; Wakai T
    Comput Struct Biotechnol J; 2021; 19():3330-3338. PubMed ID: 34188781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences.
    Tortora SC; Bodiwala VM; Quinn A; Martello LA; Vignesh S
    World J Gastrointest Oncol; 2022 Feb; 14(2):375-395. PubMed ID: 35317317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of MicroRNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer.
    Xing J; Liao Y; Zhang H; Zhang W; Zhang Z; Zhang J; Wang D; Tang D
    Front Cell Infect Microbiol; 2022; 12():804689. PubMed ID: 35493741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiome and colorectal cancer: a review of bacterial pathogenesis.
    Dahmus JD; Kotler DL; Kastenberg DM; Kistler CA
    J Gastrointest Oncol; 2018 Aug; 9(4):769-777. PubMed ID: 30151274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomic analysis of the interaction between the gut microbiota and colorectal cancer: a paired-sample study based on the GMrepo database.
    Chen H; Jiao J; Wei M; Jiang X; Yang R; Yu X; Zhang G; Zhou X
    Gut Pathog; 2022 Dec; 14(1):48. PubMed ID: 36564826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India.
    Gupta A; Dhakan DB; Maji A; Saxena R; P K VP; Mahajan S; Pulikkan J; Kurian J; Gomez AM; Scaria J; Amato KR; Sharma AK; Sharma VK
    mSystems; 2019 Nov; 4(6):. PubMed ID: 31719139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A newly developed PCR-based method revealed distinct Fusobacterium nucleatum subspecies infection patterns in colorectal cancer.
    Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Wei Q; Qin H
    Microb Biotechnol; 2021 Sep; 14(5):2176-2186. PubMed ID: 34309194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.